These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12243508)
1. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Tang D; Cho S; Rundle A; Chen S; Phillips D; Zhou J; Hsu Y; Schnabel F; Estabrook A; Perera FP Breast Cancer Res Treat; 2002 Sep; 75(2):159-66. PubMed ID: 12243508 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Crew KD; Gammon MD; Terry MB; Zhang FF; Zablotska LB; Agrawal M; Shen J; Long CM; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2033-41. PubMed ID: 17932351 [TBL] [Abstract][Full Text] [Related]
4. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Tang D; Rundle A; Mooney L; Cho S; Schnabel F; Estabrook A; Kelly A; Levine R; Hibshoosh H; Perera F Breast Cancer Res Treat; 2003 Mar; 78(2):217-22. PubMed ID: 12725421 [TBL] [Abstract][Full Text] [Related]
5. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466 [TBL] [Abstract][Full Text] [Related]
6. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488 [TBL] [Abstract][Full Text] [Related]
7. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Stern MC; Johnson LR; Bell DA; Taylor JA Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500 [TBL] [Abstract][Full Text] [Related]
8. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Liang G; Xing D; Miao X; Tan W; Yu C; Lu W; Lin D Int J Cancer; 2003 Jul; 105(5):669-73. PubMed ID: 12740916 [TBL] [Abstract][Full Text] [Related]
9. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004 [TBL] [Abstract][Full Text] [Related]
10. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population. Radwan WM; Elbarbary HS; Alsheikh NM Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768 [TBL] [Abstract][Full Text] [Related]
11. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Rybicki BA; Conti DV; Moreira A; Cicek M; Casey G; Witte JS Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):23-9. PubMed ID: 14744728 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Yu HP; Wang XL; Sun X; Su YH; Wang YJ; Lu B; Shi LY; Xiong CL; Li YY; Li F; Xu SQ Cancer Genet Cytogenet; 2004 Oct; 154(1):10-5. PubMed ID: 15381366 [TBL] [Abstract][Full Text] [Related]
13. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Matullo G; Palli D; Peluso M; Guarrera S; Carturan S; Celentano E; Krogh V; Munnia A; Tumino R; Polidoro S; Piazza A; Vineis P Carcinogenesis; 2001 Sep; 22(9):1437-45. PubMed ID: 11532866 [TBL] [Abstract][Full Text] [Related]
14. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Vogel U; Hedayati M; Dybdahl M; Grossman L; Nexø BA Carcinogenesis; 2001 Jun; 22(6):899-904. PubMed ID: 11375896 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer. Rundle A; Tang D; Hibshoosh H; Schnabel F; Kelly A; Levine R; Zhou J; Link B; Perera F Environ Mol Mutagen; 2002; 39(2-3):201-7. PubMed ID: 11921190 [TBL] [Abstract][Full Text] [Related]
17. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers. Pavanello S; Pulliero A; Siwinska E; Mielzynska D; Clonfero E Carcinogenesis; 2005 Jan; 26(1):169-75. PubMed ID: 15471894 [TBL] [Abstract][Full Text] [Related]
18. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Pastorelli R; Cerri A; Mezzetti M; Consonni E; Airoldi L Int J Cancer; 2002 Jul; 100(1):9-13. PubMed ID: 12115580 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287 [TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms of BAG-1 and XPD and chemotherapy sensitivity in advanced non-small-cell lung cancer patients treated with vinorelbine combined cisplatin regimen. Li P; Wang YD; Cheng J; Chen JC; Ha MW Tumour Biol; 2015 Dec; 36(12):9465-73. PubMed ID: 26124006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]